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Background: Ageing affects many components of the immune system, including innate immune cells like
monocytes. They are important in the early response to pathogens and for their role to differentiate into
macrophages and dendritic cells. Recent studies have revealed significant age-related changes in genomic DNA
methylation in peripheral blood mononuclear cells, however information on epigenetic changes in specific
leukocyte subsets is still lacking. Here, we aimed to analyse DNA methylation in purified monocyte populations
from young and elderly individuals.
Findings: We analysed the methylation changes in monocytes purified from young and elderly individuals using
the HumanMethylation450 BeadChip array. Interestingly, we found that among 26 differentially methylated CpG
sites, the majority of sites were hypomethylated in elderly individuals. The most hypomethylated CpG sites were
located in neuropilin 1 (NRP1; cg24892069) and neurexin 2 (NRXN2; cg27209729) genes, and upstream of miR-29b-2
gene (cg10501210). The age-related hypomethylation of these three sites was confirmed in a separate group of
young and elderly individuals.
Conclusions: We identified significant age-related hypomethylation in human purified monocytes at CpG sites
within the regions of NRP1, NRXN2 and miR-29b-2 genes.
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Innate and adaptive immune responses are affected by
ageing. Elderly people have a decreased ability to main-
tain basic tissue homeostasis, impaired vaccination re-
sponses and an increased risk for infectious diseases,
particularly influenza virus [1-4]. A diverse range of age-
associated changes has been reported in human innate
immune cells [3,5], which are important during the early
response to pathogens. Monocytes, which are circulating
cells that originate from myeloid precursors, are the pre-
cursors of tissue macrophages and dendritic cells and con-
stitute an essential part of the innate immune system.
Although the number of monocytes does not change sig-
nificantly during ageing, several functional age-related
changes in monocytes, such as altered expression of* Correspondence: liina.tserel@ut.ee
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stated.cytokines, defective Toll-like receptor signalling and a de-
creased capacity for phagocytosis, have been reported [6].
Monocytes are also involved in the initiation of athero-
sclerosis on arterial walls and have been linked to a chronic
inflamed state (referred to as inflamm-ageing), which is
associated with increased cardiovascular and metabolic
diseases in elderly individuals [7]. Recent studies have re-
vealed the important role of epigenetic regulation in the
development and cell-specific functions of blood cells.
Changes in DNA methylation patterns occur gradually
throughout an individual’s lifespan [8,9] and may result in
the age-related phenotypes of a specific set of genes [8].
The majority of these studies have examined DNA methy-
lation changes in a mixed population of peripheral blood
mononuclear cells (PBMCs) without purifying specific
subsets of cells. In this study, we aimed to analyse the epi-
genomic changes in DNA methylation in purified mono-
cyte cell populations from young and elderly individuals.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
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isolated monocytes from the peripheral blood of eight
young (age range 22–25 years, mean 23.75 years; 4 fe-
males and 4 males) and eight elderly healthy volunteers
(age range 77–78 years, mean 77.13 years; 4 females and
4 males). A whole genome methylation analysis was
performed using the Infinium HumanMethylation450
BeadChip (Illumina Inc.). Altogether, we found 368 CpG
sites that were significantly differentially methylated
(p < 0.05), of which 26 CpG sites had an absolute β
value differences greater than or equal to 0.2 between the
young and old individuals (Table 1). Most of the CpG
sites, a total of 21 positions, were hypomethylated in the
elderly individuals; only five positions were hypermethy-
lated in these individuals. Decreased methylation duringTable 1 Differentially methylated sites in young versus
old monocyte cell populations
Target ID β-difference* Adjusted p-value Gene
cg10501210 −0.38 0.002884 miR-29b-2**
cg24892069 −0.30 0.00312 NRP1
cg27209729 −0.30 0.020571 NRXN2
cg11807280 −0.27 0.013523
cg08128734 −0.27 0.015965 RASSF5
cg11693709 −0.26 0.024853 PAK6
cg18826637 −0.25 0.022927
cg00329615 −0.25 0.012874 IGSF11
cg00740914 −0.25 0.008061
cg03873281 −0.25 0.005647 PDLIM4
cg13039251 −0.23 0.008793 PDZD2
cg07583137 −0.23 0.007904 CHMP4C
cg12317815 −0.22 0.014773 ASPA
cg06781608 −0.22 0.030063 PTPRN2
cg13001142 −0.22 0.011913 STXBP5
cg16932827 −0.21 0.015062
cg19344626 −0.21 0.010547 NWD1
cg14295611 −0.21 0.04857
cg14614643 −0.21 0.008462
cg03915012 −0.21 0.026415 GAK
cg03473532 −0.20 0.035003 MKLN1
cg02978201 0.47 0.015062 PRM1
cg04875128 0.30 0.017558 OTUD7A
cg21184711 0.23 0.024671 CADPS2
cg20665157 0.22 0.008629 CADPS2
cg19907915 0.21 0.014934 IGSF9B
The three replicated CpG loci are shown in bold.
*A negative β-difference indicates to hypomethylation in the elderly and a
positive β-difference indicates to hypermethylation in the elderly population.
Only CpG sites with FDR-adjusted p-values less than 0.05 were considered
differentially methylated.
**Approximately 1 kb upstream.the ageing process has been previously described in a
study of PBMCs [10]. The most significantly altered sites
mapped within the NRP1, NRXN1, RASSF5, OTUD7A
and PRM1 genes. The loci that did not reach the 0.2
β-difference threshold but were significantly different
(p < 0.05) included two ELOVL2 sites, cg16867657 and
cg24724428 (both with β-diff. of 0.17); two FHL2 sites,
cg22454769 and cg24079702 (β-diff. of 0.15 and 0.14, re-
spectively); and a PENK site, cg16419235 (β-diff. of 0.08);
all these sites are associated with increased methylation
in the peripheral blood mononuclear cells of older in-
dividuals [9,10].
To validate our results, we focused our investigation
on the three differentially methylated CpG sites with the
highest hypomethylation values, cg24892069, cg27209729
and cg10501210. The CpG site cg24892069, which had a
very low standard deviation in both age groups (young
STDEV: 0.05; old STDEV: 0.06), is located in intron 2 of
the neuropilin 1 (NRP1) gene. NRP1 is a cell surface re-
ceptor with functional roles in several biological processes,
including angiogenesis, immune response and regulation
of vascular permeability [11,12], and has also been associ-
ated with increased cancer progression [13,14]. NRP1 is
expressed in regulatory T cells [15] and is needed for pro-
longed cellular contact between regulatory T-cells and
dendritic cells [16]. Another CpG site, cg27209729, is lo-
cated in intron 9 of the neurexin 2 (NRXN2) gene.
NRXN2 is a member of the neurexin family, which affects
synaptic plasticity and cognitive functioning [17], and has
been linked to autism spectrum disorders and schizophre-
nia [18]. The third CpG site, cg10501210, is located in
putative regulatory region, approximately 1 kb upstream
of the miR-29b-2 gene. miR-29b-2 belongs to the miR-29
family, which is important in thymic involution [19],
T cell polarisation [20] and oncogenesis [19,21]. The miR-
29b has been shown to target DNA methyltransferases
DNMT3A and DNMT3B, and indirectly DNMT1 [22,23],
leading to reduction of global methylation and expression
of methylation regulated genes.
We replicated the array results of the three differentially
methylated loci using the EpiTYPER assay (Sequenom
Inc.) with a separate set of young and elderly samples. We
added to our analyses two sex-matched control age
groups, consisting of 10 young (age range 24–28 years,
mean 26.4 years; 5 men and 5 females) and 10 elderly (age
range 76–84 years, mean 79.4 years; 5 men and 5 females)
samples. Using the EpiTYPER assay, we found hypome-
thylation of the NRP1-associated cg24892069 site in
the monocytes of the older individuals, similar to the re-
sults from the HumanMethylation450 BeadChip analysis
(Figure 1A). We also analysed the methylation differences
in men and women separately and observed a significant
difference in both gender groups (p < 0.0001) (Figure 1B).
To explore this region further, we selected another CpG
Figure 1 Percentage of methylation of CpG sites cg24892069
(NRP1; A & B) and cg24892069-40 bp (NRP1; C & D). The mean
(±S.E.M.) methylation difference measured in 18 young and 17 old
individuals using the Sequenom’s EPITYPER assay.
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of the cg24892069 site in the genomic sequence; this site
was not included on the methylation BeadChip. We found
that the cg24892069-40 bp site had a statistically signifi-
cant methylation difference between the studied age
groups (p < 0.0001) (Figure 1C) and that was observed in
both sexes (p < 0.0001) (Figure 1D). The similar DNA
methylation pattern of the two CpG sites in close proximity
is most likely the result of a shared, differentially methyl-
ated, region that is modified from the nearby methyltrans-
ferase binding site. We also found significant differences
between the age groups at the cg27209729 and cg10501210
sites, located in the NRXN2 gene and upstream of the miR-
29b-2 gene, respectively (Figure 2). These CpG sites had
statistically significant methylation differences in the com-
bined study group (p < 0.0001) (Figure 2 A&C) as well as inFigure 2 Percentage of methylation of CpG sites cg27209729
(NRXN2; A & B) and cg10501210 (miR-29b-2; C & D). The mean
(±S.E.M.) methylation difference measured in 18 young and 15 old
individuals using the Sequenom’s EPITYPER assay.the male and female study groups (p < 0.01 and p < 0.0001,
respectively) (Figure 2 B&D).
We also evaluated the expression of the three differen-
tially methylated CpG sites in monocytes of young and
elderly individuals, but the expression levels NRP1 and
NRXN2 genes were under the detection limit of RT-
PCR. This is in agreement with our previously published
mRNA expression study, where NRP1 was expressed at
very low levels in monocytes and demonstrated a signifi-
cantly increased expression in monocyte-derived dendritic
cells and macrophages, whereas NRXN2 expression
remained low even after the differentiation to dendritic
cells [24]. The mRNA level of miR-29b-2 gene was detect-
able, however, the expression between young and elderly
individuals did not differ significantly (data not shown).
As the CpG site cg10501210 is located approximately 1 kb
upstream of miR-29b-2 gene, it might not have regulatory
effect on miR-29b-2 gene expression.
In conclusion, we were able to identify age-related
DNA methylation changes in purified monocytes at im-
munologically relevant genomic loci. We found that the
majority of the altered CpG sites were hypomethylated
in the elderly individuals. The top three hypomethylated
CpG sites in the elderly were cg24892069, cg27209729
and cg10501210, which are located in or near the NRP1,
NRXN2 and miR-29b-2 genes, respectively. Further in-
vestigation and a larger sample set are needed to define
the functional role and significance of these CpG sites in
the ageing process.
Material and methods
Purification of cell populations
The study is approved by Ethics Review Committee on
Human Research of the University of Tartu. All of the
participants gave written informed consent. Peripheral
blood was obtained from healthy donors of Estonian
Genome Center of University of Tartu. Peripheral blood
mononuclear cells (PBMC) were extracted using a Ficoll-
Paque (GE Healthcare) gradient centrifugation. CD14+
monocytes were extracted from PBMCs using microbeads
(CD14+ #130-050-201) and AutoMACS technology
(Miltenyi Biotec). The purity of monocyte cell popula-
tion was analysed with FACSCalibur (BD Biosciences)
using fluorescence conjugated antibodies against CD14
and CD3 (Miltenyi) to confirm the characteristic pheno-
type (Additional file 1: Figure S1).
DNA extraction, bisulfite treatment and DNA methylation
measurement
Genomic DNA was isolated from cell pellets using QIAmp
DNA Micro Kit (Qiagen). DNA concentration was mea-
sured with NanoDrop ND-1000 spectrophotometry. Ex-
tracted genomic DNA was bisulfite converted using EZ-96
DNA Methylation Kit (Zymo Research Corporation). DNA
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Human Methylation 450 K bead chip technology (Illumina).
Sequenom EpiTYPER assay
The Sequenom EpiTYPER technology was used to validate
HumanMethylation450 array data. Samples were prepared
using EpiTYPER T Complete Reagent Set (Sequenom) ac-
cording to manufacturer’s instructions. 25 ng of bisulfite-
treated DNA was used as PCR input and CpG methylation
was determined by the MassARRAY Analyzer 4 system
(Sequenom).
Data analyses
The methylation signals were extracted with the methy-
lation module v1.8.5 of the GenomeStudio v2010.3 soft-
ware (Illumina Inc.) without background correction and
normalisation. Probes with a detection p-value greater
than 0.01, located on sex chromosomes or containing
SNPs with a minor allele frequency of at least 5% in the
Caucasian population according to the Hapmap project
(http://hapmap.ncbi.nlm.nih.gov) were filtered out prior
further analysis. The signals were corrected and normal-
ised using subset quantile normalisation as described in
[25]. For differential methylation analysis, 80% of the
least varying probes according to interquartile range
across all samples were removed and a linear model was
used to assess the differences between two age groups
considering arrays on different BeadChips as batches.
Methylation sites with a FDR adjusted p-value less than
0.05 were considered differentially methylated. Median
difference of beta values greater than 0.2 between groups
was considered for selecting methylation sites for further
analyses.
Additional file
Additional file 1: Figure S1. The purification of monocyte cell
population. The monocytes were analysed with FACSCalibur (BD
Biosciences) using fluorescence conjugated antibodies against CD14 and
CD3 (Miltenyi).
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